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 Many individual hosts are infectedwithmultiple parasite species, and thismay increase or decrease the pathogenicity
of the infections. This phenomenon is termed heterologous reactivity and is potentially an important determinant of
both patterns ofmorbidity andmortality and of the impact of disease control measures at the population level. Using
infections with Theileria parva (a tick-borne protozoan, related to Plasmodium) in indigenous African cattle [where it
causes East Coast fever (ECF)] as a model system, we obtain the first quantitative estimate of the effects of
heterologous reactivity for any parasitic disease. In individual calves, concurrent co-infection with less pathogenic
species of Theileria resulted in an 89% reduction inmortality associated with T. parva infection. Across our study pop-
ulation, this corresponds to a net reduction inmortality due to ECF of greater than 40%. Using amathematical model,
we demonstrate that this degree of heterologous protection provides a unifying explanation for apparently disparate
epidemiological patterns: variable disease-inducedmortality rates, age-mortality profiles, weak correlations between
the incidence of infection and disease (known as endemic stability), and poor efficacy of interventions that reduce
exposure tomultiple parasite species. These findings can be generalized tomany other infectious diseases, including
human malaria, and illustrate how co-infections can play a key role in determining population-level patterns of mor-
bidity and mortality due to parasite infections. scie o
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For many host-pathogen combinations, there is wide variability in the
clinical outcome of an infection, ranging from subclinical (no symp-
toms or signs) through clinical illness to death. Understanding the
causes and consequences of this variability is among the biggest chal-
lenges in biomedical research. Differences between individual hosts
(variously attributed to genetics, environment, or demographics, espe-
cially age) and between pathogen strains may all be important (1, 2).
However, hosts may also differ in their history of infection by multiple
other pathogen types (3–5). An influence of past or current infection
with one pathogen species on the outcome of infection with another
is termed heterologous reactivity.1Centre for Immunity, Infection and Evolution, University of Edinburgh, Ashworth Lab-
oratories, Kings Buildings,WestMains Road, Edinburgh EH9 3JT, UK. 2Paul G. Allen School for
Global Animal Health, Washington State University, Pullman, WA 99164–7090, USA. 3Royal
(Dick) School of Veterinary Studies, University of Edinburgh, The Roslin Building, Easter Bush,
Midlothian EH25 9RG, UK. 4The Roslin Institute, University of Edinburgh, The Roslin Building,
Easter Bush, Midlothian EH25 9RG, UK. 5The James Hutton Institute, Craigiebuckler, Aberdeen
AB15 8QH, UK. 6International Livestock Research Institute, P.O. Box 30709, Nairobi 00100,
Kenya. 7Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University
of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa. 8School of Life Sciences,
University of Nottingham, University Park, Nottingham NG7 2RD, UK. 9Natural Resources
Institute Finland (Luke), Green technology, FI-31600 Jokioinen, Finland. 10Henry Wellcome
Building, Institute of Biodiversity, Animal Health and Comparative Medicine, Garscube
Campus, College of Medical, Veterinary and Life Sciences, University of Glasgow, Bearsden
Road, GlasgowG61 1QH, UK. 11Divisionof Evolution, Ecology andGenetics, Research School
of Biology, The Australian National University, Canberra, Australian Capital Territory 0200,
Australia.
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2015Heterologous reactivity may have a negative impact on host health
[for example, for co-infections with influenza A and Streptococcus
pneumoniae (6)], but it can also have a protective effect (7, 8). For viruses
or bacteria, heterologous protection is often attributable to acquired im-
munity to one pathogen reducing susceptibility to subsequent infection
with a second pathogen (9, 10). However, although it has been proposed
for both human schistosomes (11) andmalaria (12), heterologous protec-
tion is not well established for parasites (13), and there have been no pre-
vious studies of its population-level impact for any parasitic disease,
reflecting both a dearth of quantitative field data and the absence of an
appropriate analytical framework. Here, we report howwe quantified the
impact of co-infections on the epidemiology and control of East Coast
fever (ECF), a parasitic disease of cattle caused by the tick-borne proto-
zoan Theileria parva. We then use an epidemiological model to explore
the implications of heterologous protection for the epidemiology and
control of ECF. The model is generic, and we expect these findings to
be applicable to other parasitic diseases of cattle, humans, or other hosts.
We studied interactions between T. parva and other Theileria species
in East African shorthorn zebu calves resident in an area of western
Kenya where endemic ECF imposes a substantial disease burden
(14, 15) (Fig. 1). This cattle breed is indigenous to East Africa and is
considered more tolerant of T. parva infection than otherwise more
productive European cattle (16). Cattle in this region are also routinely
exposed to other, much less well-studied Theileria species, most
commonly Theileria mutans and Theileria velifera. These two species
have broadly similar life cycles to T. parva but differ in several key
respects: they are carried by different tick vectors (Amblyomma spp.
rather than Rhipicephalus appendiculatus); they proliferate primarily
in erythrocytes rather than in lymphocytes; the infections are much1 of 10
R E S EARCH ART I C L Emore persistent; and, importantly, they are not associated with severe
disease (16).http://advan
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 RESULTS
Epidemiological patterns
Our data were obtained from an observational study of a birth cohort of
East African shorthorn zebu calves. Of the 454 eligible calves that sur-
vived for 1 year, serological tests indicated that 392 were exposed to
T. parva. Of the 88 eligible calves that died, 31 were determined to have
died of ECF, 1 died of turning sickness (caused by T. parva infection of
the nervous system), and 24 others were exposed to T. parva before
death from other or undetermined causes. Together, this gives a best
estimate of 448 calves exposed to T. parva during their first year, of
which 93% survived the infection.
Twenty-four ECF deaths (77%) were classified as acute, that is,
occurred within 35 days of first infection with T. parva. Of the remain-
der, five were attributed to secondary reinfection with T. parva, and two
had uncertain infection dates, so these could not be categorized. Of
calves surviving infection, 75 (18%) experienced clinical illness
consistent with acute ECF but, for the majority, no clinical signs were
detected. As previously reported (14), surviving first infection with
T. parva (using seroconversion as a marker of previous exposure)
strongly protects against subsequent ECF mortality [hazard ratio,Woolhouse et al. Sci. Adv. 2015;1:e1400196 20 March 20150.12; 95% confidence interval (CI), 0.07 to 0.22] through the develop-
ment of T cell–mediated adaptive immunity (17). The rate of exposure
toT. parva estimated from serology data (18)was near constant over the
first year of life (Fig. 2A). In contrast, both the case fatality rate (propor-
tion dying of acute ECF among those infected) and the net clinical ECF
rate (proportion dying and/or experiencing clinical illness) declined
with age (Fig. 2A). These patterns are consistent with mathematical
model predictions described below (see Fig. 2B).
When calves were infected with the less pathogenic Theileria (LPT)
species (T. mutans and T. velifera) before infection with T. parva, there
were just 2 instances out of 25 (both with T. mutans alone) where we
observed ECF-like clinical signs (compared with 29 of 53 when infected
with T. parva alone, a significant difference: Fisher’s exact test, P <
0.001). T. velifera was never found in the absence of both T. parva
and T. mutans. These data confirm that LPT do indeed have low path-
ogenicity in this population.
Natural challenge experiment
To test for evidence of heterologous protection by LPT, we exploited the
longitudinal nature of our cohort study to design a large “natural chal-
lenge” experiment involving all 310 calves that did not seroconvert to
T. parva (or die from acute ECF) until >16 weeks old. Of these calves, o
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Fig. 1. Map of study area in western Kenya. Map shows location of the
study area and distinguishes different agroecological zones. Calves were re-
cruited from 20 different sublocations (red), all falling within 45 km from the
IDEAL project field laboratory in Busia town.Fig. 2. Age-related variation in risks of T. parva infection, clinical ill-
ness, and death from ECF. (A) Empirical estimates of (i) hazard of sero-
conversion to T. parva (18), with censoring of non–T. parva–related deaths
and adjusted for a 14-day delay between infection and a detectable anti-
body response; (ii) case fatality rate (probability of death conditional on in-
fection, CF); (iii) net clinical rate (probability of death or ECF-like illness
conditional on infection, CL). In contrast to hazard, CF and CL both decrease
with age (Poisson regression: F1,8 = 10.4, P = 0.012 and F1,8 = 57.7, P < 0.001,
respectively). (B) Model-predicted estimates for hazard and corresponding
predictions for CF and CL with age. Model equations are given in Materials
and Methods; parameter estimates are as in Table 3.2 of 10
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 169 had seroconverted to T. mutans by 16 weeks old, and 141 had not.
We askedwhether the outcome of subsequentT. parva infection, that is,
acute ECF death or survival, was associated with serological evidence of
exposure toT.mutans at 16weeks. The natural challenge experiment has
the advantage that it is considerably larger thanwould be feasible in a true
experiment.However, becauseT.mutans status is not assigned randomly,
the approach requires that there is nobias betweenT.mutans seropositive
and seronegative calves with respect to factors potentially influencing the
ECF case fatality rate. The requirement was met for all key indicators.
There was minimal difference in the mean age of subsequent sero-
conversion toT. parva among survivors (32 and 31weeks for seropositive
and seronegative calves, respectively). The two groups had similar levels
of infections with strongyle worms at week 16 [median, 325 and 250 eggs
per gram (epg), respectively]; this is a possible confounder of the
effect ofT.mutanson clinical outcome ofT. parva infection (14). Finally,
there were seven deaths in each group (median age = 41weeks for both)
due to causes other than acute ECF.
Two calves in the T. mutans seropositive group died of acute ECF
before 1 year of age, compared with nine calves in the T. mutans sero-
negative group (Fig. 3A). The difference in acute ECF mortality rate
(Fig. 3A) was statistically significant [log-rank test: c2(1) = 6.2, P =
0.013], and the size of the protective effect and the trend to decrease over
time (Fig. 3A) were both consistent with the predictions of amathemat-
ical model (see below). This result is consistent with heterologous pro-
tection, but serology does not indicate whether the T. mutans infection
is still active or has been cleared.
Case-control study
We proceeded to study the infection histories of a subset of the calf co-
hort using a polymerase chain reaction (PCR)–based test, the reverse
line blot (RLB) hybridization assay, which detects active infections
(seeMaterials andMethods) and is better suited than serology to deter-
mine infection histories in the youngest calves because of the presence
ofmaternal antibodies.We conducted a nested case-control study using
105 calves: all 24 calves that died of acute ECF (cases) and an age-
matched subsample of 81 of the 392 calves that survived exposure to
T. parva (controls). Cases and controls had mean ages of 113 and
107 days, respectively. These calves were screened for the presence of
other species of Theileria parasites at every time point between birth
and seroconversion to T. parva (or death) using RLB. For statistical
analysis, we defined four age classes (Fig. 3B and Table 1), noting that
the earliest detection of T. parva was at 16 days old. Exact conditional
logistic regression indicated that concurrent infection with LPT at first
infection with T. parva was associated with an 89% reduction (95% CI,
47 to 99%; P= 0.002) in the odds of dying of ECF (Fig. 3B and Table 2A).
The analysis controlled for the increase in LPT prevalence with age,
noting that LPT prevalence in calves when they were first infected with
T. parvawas very similar to LPT prevalence in calves of the same age but
not infected with T. parva (Fig. 3C).
Wedid not find any association of outcomewith other co-infections,
for example, strongyle nematodes or the tick-borne rickettsia Ehrlichia
spp. and Anaplasma spp., and the association between outcome and
LPT was robust to the inclusion of these as covariates in the analysis
(Table 2A). The association was also robust to the inclusion of any of
>40 other covariates relating to the calf, its dam, or its environment (see
the Supplementary Materials).
Incorporation of previous LPT status in the predictor variable did
not improve model fit (Table 2B), indicating that protection was mostWoolhouse et al. Sci. Adv. 2015;1:e1400196 20 March 2015strongly associated with concurrent LPT infection. Nonetheless, be-
cause LPT causes chronic infections, the protective effect may be
long-lived. However, if calves do clear LPT infection, then they revert
to a level of risk that is statistically indistinguishable from calves that
were never infected (odds ratio = 1.21; 95% CI, 0.26 to 5.52; Table 2B).Fig. 3. Epidemiology of LPT infections and relationships with clinical
outcomeof T. parva infection. (A) Kaplan-Meier plot for calves first infected
by T. parva at >16 weeks of age. Observed fractions surviving for those ini-
tially exposed (n = 169) and unexposed (n = 141) to LPT are compared. Tick
marks indicate censoring (due to non-ECF deaths or end of observation pe-
riod). A log-rank test indicates a significant difference [c2(1) = 6.2, P = 0.013].
The change in overall relative risk for the two groups (CF ratio) as the calves
age indicates falling levels of protection and is consistent withmodel predic-
tions (see table S2). (B) Numbers of case and control calves by age class (1 to
4; see Table 1) and detection or nondetection of LPT, having excluded five
calves with unknown LPT status. Controlling for age, detection of LPT is sig-
nificantly protective (odds ratio = 0.11, P = 0.002). (C) Comparison of ob-
served age-related LPT prevalences at time of first detection of T. parva
surviving case-control calves (n= 81) in different age classes andoverall (with
95% CIs) with expected prevalences averaged over all visits when T. parva
was not detected. Expected prevalences in surviving calves from a mathe-
matical model (see main text) are compared.3 of 10
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 If ECF mortality were associated with only specific, rare T. parva
strains, this could explain the low and age-related case fatality rate
(although not the association with LPT). However, every individual
infection of a subset that was genotyped exhibited a low number of al-
leles per locus (means of 1.09 to 1.18) together with a low expected het-
erozygosity (0.029 to 0.178). In contrast, a much higher level of
heterozygosity (0.5 to 0.843) was observed in the overall population,
calculated on the basis of the predominant multilocus genotypes.
We interpret these data as indicating that each calf is infected with
a low number of T. parva genotypes, and that a single, highly abun-
dant genotype predominates in each calf, but the predominant geno-
type varies from calf to calf with no obvious clustering of genotypes.
So, there is evidence of a high level of diversity present in the T. parva
population, consistent with previous studies (19), but no indication
that there is a single pathogenic genotype circulating in the cattle
population.
To investigate the physiological effects of concurrent LPT infection,
we characterized the initial (pre-seroconversion) response to T. parva
infection for a subset of 68 calves in the case-control study using a com-
bination of hematological and immunological variables combined in a
single index of clinical “severity” (see the SupplementaryMaterials). Se-
verity, thus defined, was closely associated with whether calves re-
mained healthy or died (table S1). However, calves that became
clinically ill had similar severity scores to those that died (fig. S1). Given
this observation, we looked for an association between LPT and clinical
ECF in all surviving calves. Calves that were clinically ill had an LPT
prevalence intermediate between those that remained healthy and those
that died (fig. S2). We interpret these results as calves that died being at
the extreme end of a clinical spectrum that is strongly influenced by the
presence or absence of LPT.
Mathematical modeling
We used a mathematical model to explore the epidemiological con-
sequences of heterologous protection against infectious disease in an
endemic setting. The model (see Materials and Methods) considers
the cumulative fraction of hosts of age a exposed to a high pathogenicity
parasite [C(a)] and the fraction currently infected with a low pathoge-
nicity parasite [L(a)] and is potentially applicable to any combination of
parasite or pathogen species in any host. Model parameters are defined
in Table 3 and were estimated using data from the calf cohort. The keyWoolhouse et al. Sci. Adv. 2015;1:e1400196 20 March 2015model output is U(a), the age-specific rate at which hosts are first
exposed to high pathogenicity infection in the absence of concurrent low
pathogenicity infection, whereU(a) =LH(1 −C(a))(1 − L(a)). These hosts
do not benefit from heterologous protection and so have elevated caseTable 1. Case-control study. Age distribution of ECF deaths (cases) and
age-matched, T. parva–exposed but surviving calves (controls). The
conditional logistic regression analysis (see Materials and Methods)
controls for any imbalance across age classes. The number of deaths
by age class predicted by the mathematical model (see Material and
Methods) is compared.Age
classAge
(days)Observed no. of
deathsPredicted no. of
deathsNo. of
survivors1 15–59 7 10.5 282 60–104 8 5.4 173 105–159 5 3.1 174 160+ 4 5.1 19All 24 81Table 2A. Conditional logistic regression analyses of case-control
data. Each row shows results from a model including the variable or varia-
bles shown. All models include age stratification (see Table 1). Odds ratios
give the effect of the respective predictors on the odds of death by ECF.
AICc is the corrected Akaike information criterion. Bold type indicates
models with relative probabilities ≥0.05. (A) Co-infection predictors, uni-
variate and bivariate analyses. The bivariate model with both LPT and
strongyle epg is the best fit; however, the univariate model with LPT only
has a relative probability >0.05 and generates a very similar odds ratio.
EA, Ehrlichia/Anaplasma.Predictor(s) Odds ratio (95% CI) P AICcT. mutans +ve 0.13 (0.01–0.66) 0.008 76.88T. velifera +ve 0.25 (0.01–1.94) 0.31 83.64T. mutans +ve 0.15 (0.02–0.80) 0.02 78.44T. velifera +ve 0.47 (0.01–4.6) 0.87LPT +ve 0.11 (0.01–0.53) 0.002 74.62EA +ve 0.79 (0.23–2.68) 0.87 85.72LPT +ve 0.09 (0.01–0.51) 0.002 76.29EA +ve 1.44 (0.40–5.3) 0.72Strongyle epg 0 versus 2 2.8 (0.42–21) 0.039 82.401 versus 2 0.70 (0.16–3.1) 0.80LPT +ve 0.10 (0.01–0.51) 0.002 72.56Strongyle epg 0 versus 2 2.4 (0.30–21) 0.591 versus 2 0.63 (0.12–3.3) 0.75Table 2B. Temporal predictors. LPT indicates status at time T0, LPT(T-1)
indicates status at time T-1 (35 days earlier), and LPTever indicates whether
infected at any time up to and including T0. In univariate analyses, current
LPT status alone is the best predictor; incorporating variables relating to
previous LPT status increases the AICc value. Comparing different se-
quences of LPT status for times T-1 and T0 (−ve/−ve, +ve/+ve, −ve/+ve,
+ve/−ve) in a multivariate analysis confirms that protection is associated
with LPT-positive status at time T0.Predictor(s) Odds ratio (95% CI) P AICcLPT +ve 0.11 (0.01–0.53) 0.002 74.62LPT and/or LPT(T-1) +ve 0.30 (0.07–1.09) 0.07 85.06LPTever +ve 0.37 (0.09–1.50) 0.19 86.83LPT(T-1)/LPT −ve/−ve 0.07 77.96+ve/+ve 0.20 (0.02–1.89)−ve/+ve 0.09 (0.01–0.73)−ve/+ve 1.21 (0.26–5.52)4 of 10
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 fatality and net clinical ECF rates. Hosts that were never infected and
hosts that have cleared low pathogenicity infections are both included
in U(a). The use of a single force of infection, LL, for LPT is supported
by the highly correlated distributions of LPT species (association test for
detection of T. mutans and T. velifera by RLB at 1 year old: odds ratio =
6.8, c2 = 78.9, P < 0.001). The model does not specify the mechanism
underlying heterologous protection; this could, in principle, comprise di-
rect competition between parasite species, nonspecific innate immune re-
sponses, or cross-reactive adaptive immune responses.
For Theileria infections in these calves, best-fit parameter estimates
(Table 3) indicate that LL is almost 2× greater than LH (so that young
calves are likely to be infected with LPT before T. parva) and that sH is
more than 10× greater than sL [so that LPT infections have a much
longer average duration (1/sL = 43 weeks) than T. parva infections
(1/sH = 3 weeks)]. These results imply that, once infected with LPT,
most of the calves will remain infected for most or all their first year,
whereas T. parva infections are cleared rapidly to below detectable
levels, consistent with previous observations (16). Our estimates of
the scaling parameters m and h correspond to 12% of high-risk calves
(U) dying and a further 37% becoming clinically ill, in good agreement
with estimated case fatality (CF) and net clinical (CL) rates in the youn-
gest calves (12 and 42%, respectively; Fig. 3A).
The model makes a number of predictions that constitute internal
validation tests. First, the model predicts LPT prevalence by age in sur-
viving calves in the case-control study, showing good agreement be-
tween prediction and observation (Fig. 3C). Second, the model predicts
LPT prevalence at T0 (the periodwhenT. parvawas first detected), given
observed prevalence at T-1 (35 days earlier) as the starting condition (Fig.
3C): the central prediction was 0.45, and the model was an acceptable fit
to observed data (prevalence = 0.51; 95% CIs, 0.39 to 0.62; c2 test, P =
0.32). Third, the model predicts the age distribution of deaths (Table 1)
andprovides an acceptable fit to thedata [c2(3)= 2.82,P=0.42], although
numbers are too low to differentiate reliably from a model without
heterologous protection [same comparison: c2(3) = 4.71, P = 0.19].
Consistent with the field data (Fig. 2A), the model predicts a con-
stant value for the rate of infection with T. parva, but marked age-
related decreases in both CF and CL (Fig. 2B), more so if the force of
infection with LPT (LL) is high and/or if the rate of clearance of LPT
infections (sL) is low (Fig. 4). In the absence of heterologous protec-
tion, the model predicts constant CF and CL with age (Fig. 4).Woolhouse et al. Sci. Adv. 2015;1:e1400196 20 March 2015As sensitivity analyses, we compared model-predicted changes in
CF with age for different parameter combinations. The results (Fig. 4)
illustrate the comparative influence of LL and sL on CF as a function
of age: increasing LL lowers CF overall, but especially in younger calves;
decreasing sL also lowers CF overall, but especially in older calves.
High LL and low sL together result in very low CF in all but the very
youngest calves.
Model-predicted, overall fractions of exposed and high-risk calves
during the first year of life (C1 and U1, respectively) and overall case
fatality rate (CF1) were compared for three scenarios: (A) varying LL
alone; (B) varying LH alone; (C) varying both LH and LL by the same
factor. All of these could represent natural variation in forces of infection,
for example, due to variation in tick densities (20), but scenario B also
corresponds to T. parva–specific interventions (for example, vaccination—
see below) and scenario C to nonspecific interventions (for example,
tick control using acaricides).
In scenario A, decreasing LL does not change exposure to T. parva
but substantially increases both CF1 (Fig. 5A) and net ECFmortality.
When LL = 0, 82% of calves are exposed to high-risk T. parva infec-
tions during their first year of life, and the overall case fatality rate isTable 3. Parameter definitions and best-fit estimates for mathematical model.Parameter Description Source data Central estimate (95% CI)LH Force of infection with T. parva Fraction ever infected with T. parva 0.0352 week
–1
(0.0315–0.0388)LL Force of infection with LPT Fraction of T. parva–exposed calves ever infected with LPT 0.0685 week
–1
(0.0576–0.0800)sH Rate of loss of T. parva Fraction of calves with T. parva infection by RLB at 1 year 0.335 week
–1
(0.256–0.450)sL Rate of loss of LPT Fraction of calves with LPT infection by RLB at 1 year 0.0234 week
–1
(0.0194–0.0278)m Fraction of high-risk calves that die Scaled to observed no. of acute ECF deaths 0.118
(0.079–0.168)h Fraction of high-risk surviving calves with clinical ECF Scaled to observed no. of acute ECF deaths + ECF illness 0.486
(0.415–0.556)Fig. 4. Sensitivity analysis of mathematical model. Sensitivity analysis of
model-predicted, age-related changes in the case fatality rate (CF) for differ-
ent values of the force of infection with LPT (LL) and the rate of clearance of
LPT infections (sL). LL and sL are varied as indicated, baseline and other
parameter values as in Table 3, and high LL indicates 2× the baseline and
low sL corresponds to a value of zero. CF is constant with age in the absence
of heterologous protection by LPT.5 of 10
R E S EARCH ART I C L E12%. In terms of the ECF burden in our study population, if LPT
were absent, themodel predicts a 75% increase in deaths due to acute
ECF (allowing for nonzero mortality in co-infected calves; Fig. 3B),
which equates to a 24% increase in total deaths. These results illus-
trate that we expect variation in ECF burden to reflect the value ofLL
as well as LH.
In scenario B, a 75% reduction inLH only (from 2× to 0.5× baseline)
results in a >50% fall in the fraction of calves at high risk,U1 (Fig. 5B). InWoolhouse et al. Sci. Adv. 2015;1:e1400196 20 March 2015
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equivalent reduction in LL results in a much smaller (~10%) fall in
U1, but correspondingly higher CF1 (given that net exposure toT. parva
is unchanged; Fig. 5C). For other plausible sets of parameter values,
scenario C can result in increases in both U1 and CF1. The model thus
provides a novel explanation for the puzzling phenomenon of endemic
stability, where substantial variation in the prevalence of T. parva
infection over a certain level results in little variation in net mortality
and morbidity due to ECF (14). The model predicts that, as a conse-
quence of heterologous reactivity, endemic stability will result when-
ever LH and LL covary (Fig. 5C).
Finally, we considered the effects of changing the prevalence of LPT
at different ages, L(a). A key result (table S2) is that the protective effect
observed in the natural challenge experiment (odds ratio = 0.18; 95%CI,
0.02 to 0.87) is consistent with that predicted by themodel (odds ratio =
0.29). The model also predicts that the size of the protective effect
should diminish over time as some positive calves clear their LPT infec-
tions and some negative calves acquire LPT infection (cf. Fig. 3A). o
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 DISCUSSION
This study provides three strands of evidence for heterologous protec-
tion against ECF in a population of indigenous African cattle. The
natural challenge analysis indicates that LPT status predicts clinical out-
come; the case-control study quantifies the level of protection; and the
mathematical model of heterologous protection successfully predicts
key features of the epidemiology of ECF. Future work should include
experimental studies both to confirm these observations and to deter-
mine the mechanisms underlying heterologous protection against ECF
by LPT. A working hypothesis is that the well-known immunomodu-
latory effects of T. parva (17) are moderated by the presence of LPT, so
reducing the severity of infection (noting thatwewere not able to closely
monitor cytokine levels during this study).
Our findings have implications for the epidemiology and control of
ECF. The predicted 43% decrease in deaths due to acute ECF due to the
presence of LPT represents a substantial contribution of these naturally
occurring infections to survival of indigenous cattle, a previously un-
recognized “ecosystem service” that compares favorably with the best
human efforts to control ECF and contributes to the viability of cattle
production in this region. Our analysis also explains why acaricide
spraying (which reduces exposure to all Theileria species) can fail to re-
duce disease burden (21). The results also suggest that lack of
heterologous protection may contribute to the higher ECF case fatal-
ity rate among European cattle breeds, which in this region are typ-
ically managed so as to reduce their exposure to all tick-borne
infections. The only vaccine available against ECF [the ITM (infection
and treatment method) vaccine] relies on inoculation with T. parva
parasites and simultaneous treatment with the antibiotic oxy-
tetracycline (17). Our results suggest a novel alternative approach, inoc-
ulation of young calves with more benign T. mutans or T. velifera,
without the need for treatment. The chronic nature of these infections
and the level of heterologous protection reported here suggest that this
would be an effective intervention (table S2), helping calves to survive
their first exposure to T. parva and develop immunity. Successful ECF
control would benefit an estimated 30 million cattle in sub-Saharan Af-
rica, reducing the costs of treatment as well as reducing demand for both
antibiotics and acaricides.Fig. 5. Modeling the effect of LPT infections on clinical burden due to
T. parva. (A)Model outputs for scenarioA, changing the forceof infection for
LPT species, LL (relative to baseline, scaled to 1 on horizontal axis), but not
changing LH. Baseline parameter values are as in Table 3. Fraction of calves
infectedwith T. parva before 1 year old (unchanged), high-risk infections only,
and overall case fatality rate are shown. (B) Same outputs for scenario B,
changing the force of infection for T. parva, LH, but not changing LL. (C) Same
outputs for scenario C, changingbothLH andLL. In contrast to scenario B, there
isminimal change in the fraction of calves at high risk over a fourfold change
(from 0.5 to 2) in relative forces of infection for this set of parameter values.6 of 10
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 Beyond ECF, the generic nature of our model makes its predictions
applicable to a range of infectious diseases. Theileria is just one of many
groups of closely related parasites that can co-infect their hosts and have
varying pathogenicities: others include Plasmodium spp., Trypanosoma
spp., Eimeria spp., Schistosoma spp., Babesia spp., and intestinal
helminths. For human malaria, in areas where the highly pathogenic
Plasmodium falciparum co-occurs with less pathogenic species such
as Plasmodium vivax, our analysis suggests a unified explanation for
the apparent failure of bed nets to reduce the burden of childhood dis-
ease (22), the lack of a correlation between burden and incidence of in-
fection (23), and age-related mortality due to severe malaria (24),
potentially supplanting earlier, disconnected attempts to explain these
observations (21, 24). For malaria and other human parasites, a better
understanding of the mechanisms underlying heterologous protection
may suggest novel ways to prevent clinical disease.
In host-parasite systems, where there is heterologous protection,
there are two possible host strategies for avoiding an adverse outcome of
infection: (i) being resistant to high-pathogenicity parasites, and/or (ii) be-
ing highly susceptible to and not subsequently clearing low-pathogenicity
parasites. This implies conflicting selection pressures for and against
generic susceptibility to infection, for example, to Theileria spp. and their
tick vectors in this cattle population.We speculate that theAfricanbuffalo
(Syncerus caffer) has evolved the second strategy against ECF: buffalo are
known to support extremely high prevalences and diversity of T. mutans
and T. velifera (25), and this may contribute to their very rarely suffering
clinical ECF despite high rates of exposure toT. parva (see Fig. 4). A sim-
ilar argument has been made for human malaria in the South Pacific,
where a genetic polymorphism (associated with a+-thalassemia) that in-
creases susceptibility toP. vivaxmay persist because of the protection this
gives against severe disease due toP. falciparum (12). Both these examples
imply counterintuitive adaptive benefits of increased susceptibility to in-
fection by related pathogens.
Our results illustrate a substantial reduction in the risk of morbidity
and mortality in parasite infection due to co-infection by congeneric
parasites.We suggest that heterologous protectionmay be an important
determinant of the burden anddistribution ofmanyparasitic diseases in
many host populations, including humans.m
ber 29, 2015MATERIALS AND METHODS
Study design
The Infectious Diseases of East African Livestock (IDEAL) project had
the overall objective of determining the impact of co-infections onmor-
tality and clinical disease in a birth cohort of indigenous African cattle.
The study design is described in detail elsewhere (26). Key aspects per-
tinent to this analysis are set out below.
Study population. The study was conducted in a population of
East African shorthorn zebu cattle resident in an area in western Kenya
falling within a 45-km radius of the study’s field laboratory in the town
of Busia at theKenya-Uganda border. Using a stratified (by agroecological
zone) random cluster sampling approach, study animals were selected
from smallholder farms in 20 “sublocations” (smallest administrative unit
in Kenya) (see Fig. 1). These weremixed crop-livestock smallholder farms
averaging 2 ha in size, growing food crops, and keeping an average of
five cattle plus other livestock species.
Sample size. The inclusion criteria required that the calves were
recruited into the study within 7 days of birth and born to a dam thatWoolhouse et al. Sci. Adv. 2015;1:e1400196 20 March 2015had been on the farm for at least 1 year. Only one calf per farm could be
in the study at any one time. Herds practicing stall-feeding and calves
from dams artificially inseminated were excluded to avoid recruiting
cross-bred animals. We recruited 548 calves that met these criteria. Pro-
phylaxis of any kind was rare in this population, and data from the six
calves that received anthelmintic or antibiotic treatment during the study
were censored at the time of treatment in accordancewith pre-set criteria.
Sampling. Recruitment was staggered evenly over a 2-year period
(October 2007 to September 2009) and across sublocations to control
for any seasonal and spatial variation. Calves were routinely visited at
5-week intervals until leaving the study either at death or at 1 year of age.
A complete clinical examination was conducted at the recruitment visit
and during each of the 5-week routine visits and whenever clinical ill-
ness was reported (see below). Samples including blood smears, whole
blood, serum samples, and fecal samples were collected for screening of
pathogens (see below) and for measurement of hematological and im-
munological variables. A complete list of variables recorded is given in
the SupplementaryMaterials. Visits weremade until the calf died or left
the study at 1 year.
Clinical illness. The calves’ owners and/or the resident local animal
health assistant were asked to report all episodes of clinical illness (of
any nature, including trauma) in the study calves to the project team.
These reports were followed up within 24 hours, and the calf was
subjected to a detailed examination as above. Every effort was made
to standardize reporting of clinical illness (27).We note that clinical epi-
sodes subsequently diagnosed as ECF (see below) had a very similar age
distribution toECFdeaths (Fig. 2A). Reporting and recording of all clin-
ical episodes (and deaths) were blind to the calf’s infection status.
Postmortems. For the study animals that died or were euthanized
during the study, a complete postmortem examination was carried out
by following a standard body system–by–body system veterinary post-
mortem routine (15). The study team reviewed results fromparasitolog-
ical and histological examination of samples collected at postmortem,
and gross lesions observed at postmortem, to determine the specific eti-
ological cause of death for each case.
Ethics. The study was reviewed and approved by the University of
Edinburgh Ethics Committee (reference number OS 03-06) and also
by the Institute Animal Care and Use Committee of the International
Livestock Research Institute, Nairobi. Standard techniques were used to
collect blood and fecal samples for diagnosis and identification of dis-
ease and infecting pathogens. The calves were restrained by professional
animal health assistants or by qualified veterinary surgeons. A veteri-
nary surgeon was available to examine any calf falling sick during the
course of the study. Any calf that was in severe distress due to trauma or
disease was humanely euthanized by intravenous injection of sodium
pentobarbital by a veterinary surgeon. All participating farmers gave
informed consent in their native language before recruiting their ani-
mals into the study.
Theileria diagnostics. Serological tests were performed on samples
collected during routine visits to all calves in the studyusing species-specific
enzyme-linked immunosorbent assays (ELISAs) forT. parva andT.mutans
(18). As previously (18), seroconversion was defined as a rising titer to
percent positivity (PP) >20. Seroconversion indicates an infection that
occurred at least 14 days previously and may still be active or may have
been cleared (28).
The RLB hybridization assay was performed on all samples from
calves in the case-control study (see below) up to the time of sero-
conversion to T. parva. RLB is a multiplex PCR that tests for a wide7 of 10
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 range of species of tick-borneparasites of the generaTheileria,Anaplasma,
Ehrlichia, and Babesia (29). This test detects DNA encoding the parasite
18S ribosomal RNAgene. The p104 test was carried out on calves where
ECFwas suspected on clinical grounds. This is a nested PCR test specific
to T. parva (30).
In addition, blood smears were examined for hemoparasites by mi-
croscopy. Thin smears were fixed using methanol and stained using
Giemsa. Thick smears were directly stained because no fixing was re-
quired.One hundred fieldswere examined under an oil immersion lens.
Hemoparasites present were identified to genus level, but it is not pos-
sible to distinguish individual species. The level of agreement between
the diagnostic tests was explored in detail (see the Supplementary
Materials).
T. parva genotyping. A four-marker profile was generated for 11
samples (nine fromcalves that died of ECF) using theT. parvapolymor-
phicmarkersMS2,MS8,MS19, andMS21 as described previously (31),
allowing us to estimate the most abundant multilocus genotype in each
calf and the multiplicity of infection.
Study definitions
For all the analyses reported here, we adopted the following definitions.
Seroconversion to T. parva was defined as the ELISA test giving a
rising titer to a value >20 PP (18). Seroconversion is used solely as a
marker of previous exposure to T. parva, neither maternal nor serum
antibody is protective against infection or disease (18).
First detection of infectionwas defined as the earliest visit (routine or
in response to clinical episode) at whichT. parvawas detected by one or
more of RLB, p104, or ELISA test. We note that infection dates are
therefore not known precisely (see below), nor do we have data on in-
fectious dose or on possible superinfection after first infection.
Acute ECF death is death attributed to ECF after postmortem ex-
amination and occurring less than 35 days after first detection of T.
parva infection by RLB or p104 test. The 35-day period encompasses
most ECF deaths that occur after experimental infection and, by that
time, all exposed cattle that survive are expected to have serocon-
verted (28, 32).
Clinical ECF was defined as clinical signs consistent with ECF
occurring less than 35 days (28) after first detection ofT. parva infection
or within the 35-day period up to seroconversion to T. parva. The clin-
ical signs were rectal temperature ≥40°C and enlarged lymph nodes
(16). In practice, the latter was almost always the parotid lymph node,
but for a single calf in the case-control study, ECF was diagnosed on the
basis of enlarged precrural and suprascapular lymph nodes.
Although the calves were closely monitored, incomplete ascertain-
ment or reporting of clinical ECF was possible. However, 23 of the 24
acute ECF deathswere preceded by reported clinical illness, suggesting a
high level of ascertainment for severe cases.Moreover, there is no reason
to suspect ascertainment bias for clinical illness with respect to age or
LPT status (the key variables of interest), in which case the only impact
of any underreporting would be on the estimate for the parameter h
(Table 3).
For time periods, T0was defined as the period encompassing the day
of first detection of T. parva infection plus any additional visits within
the subsequent 34 days. For calves with >1 visit during T0 (n = 24,
median time interval 11 days), we used variables measured at the first
visit that T. parvawas detected except that LPT was scored as present if
detected at any visit up to the point of seroconversion to T. parva (to
avoid false negatives). This adjustment affected only five calves (fourWoolhouse et al. Sci. Adv. 2015;1:e1400196 20 March 2015controls, one case) and is conservative with regard to the protective ef-
fect of LPT. T-1was defined as the period encompassing all visits within
the 35 days before T0.
We note that our analyses assume that a single measurement of a
predictor variable within the first 35 days of a T. parva infection is in-
formative. This is appropriate given that we are primarily concerned
here with a number of environmental predictors and with chronic
co-infections that typically persist much longer than 35 days (that is,
LPT or strongyles).
Statistical analysis
Standard two-by-two association tests were used to look at positive as-
sociation between variables. Age-related risk of seroconversion was
calculated for the entire cohortwith calves dying fromnon–ECF-related
causes censored.Changes in case fatality andnet clinical rateswith agewere
analyzed using Poisson regression implemented using SAS V9.3.1 PROC
GLIMMIX. Survival analysis was carried out using R package 2.37-7.
Natural challenge experiment. From the cohort study, we iden-
tified all calves that had not seroconverted to T. parva by 16 weeks old
but seroconverted or died of acute ECF subsequently. We divided these
into two groups: those calves that had seroconverted to T. mutans by
16 weeks old and those that had not. We compared the history of expo-
sure to T. parva and ECF mortality in the T. mutans seropositive and
T. mutans seronegative groups from 16 weeks of age. This analysis
uses seropositivity at week 16 as amarker of infection, noting the good
agreement between serology and RLB data at that age (see the Supple-
mentary Materials). A possible source of misclassification (false negatives)
was exposure to T. velifera before 16 weeks of age (because no serological
test for T. velifera is available). Inspection of the RLB data revealed just a
single instance of this, in a surviving calf; adjustment for this marginally
strengthens the result.
Case-control study. For this analysis, cases were deaths due to
acute ECF (as defined above). Controls were selected on the basis of
age at seroconversion to give the closest possible match to the age of
death of cases. The target control/case ratio was 3:1 (higher ratios give
relatively small increases in statistical power). Selection of controls was
blind to LPT status. All calves in the case-control study were screened
for the presence of different species of Theileria parasites at every time
point between birth and seroconversion to T. parva (or death) using
RLB (see above). Ages of first infection with T. parva were known only
after RLB screening and three putative cases were found not tomeet the
criteria for “acute” ECF deaths, that is, within 35 days of first infection.
Case-control data were analyzed using exact conditional logistic regres-
sion controlling for age (using four age classes). This was implemented
using SAS V9.3.1 PROC LOGISTIC.
For analysis of co-infections, univariate exact conditional logistic re-
gression was conducted with all co-infections of interest as predictors of
outcome in turn, including T. mutans positive by RLB, T. velifera pos-
itive by RLB, EApositive by RLB, and strongyle egg count category (0, 1,
or 2; see the SupplementaryMaterials, noting that countswere sufficiently
stable that solitary missing values could reasonably be interpolated if
adjacent observations were in the same category). In addition, we used
T.mutans positive andT. velifera positive in amultivariate analysis, and
then T. mutans and/or T. velifera positive as single variable, LPT. Bi-
variate conditional logistic regression was conducted with LPT and all
other co-infection variables individually to check the robustness of the
association with LPT. In addition, bivariate conditional logistic regres-
sions were conducted with LPT plus each of the variables relating to the8 of 10
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 calf’s physical environment, the calf’s dam, and the calf’s status at birth
(see above for the full list). To determine the role of previous LPT in-
fection, we defined two additional variables: LPT(T-1), that is, LPT sta-
tus 35 days earlier (see above), and LPTever, that is, whether infected
with LPT at any time up to and including T0. We also considered all
four combinations of LPT status at times T0 and T-1 as separate pre-
dictors in a multivariate analysis.
For all conditional logistic regression analyses, model fits were com-
pared using the corrected AICc, and probabilities relative to the best
model less than 0.05 (equivalent toAICc <minimumAICc + 2.30)were
noted.
Mathematical modeling
Model structure. To explore the consequences of heterologous
protection at the population level, we used a mathematical model com-
prising the following coupled differential equations:
dC
da
¼ LH 1 − CðaÞð Þ
dL
da
¼ LL 1 − LðaÞð Þ − sLL að Þ
where a is age, C is the cumulative fraction of hosts ever exposed to
a high-pathogenicity parasite species, and L is the fraction currently
infected with a low-pathogenicity species. Model parameters are
defined in Table 3.
Parameter estimation. Using numerical solutions to the model
equations, parameters LH and LL were fitted as point estimates with
binomial 95% CIs directly to the fractions of calves that were either se-
ropositive or RLB-positive for T. parva and LPT, respectively, at the fi-
nal visit (at 51 weeks old). Calves were assumed to remain free of
infection up to 14 days old, that is, C = L = 0 for a≤ 2 weeks. Although
ELISA tests are not available for T. velifera, this species was very rarely
encountered in calves that remained free of T. mutans (so any correc-
tion would be minor and well within estimated CIs). Using the same
approach, and given the central estimates ofLH andLL, sH and sL were
fitted directly to the fractions of calves that were RLB-positive for
T. parva and LPT, respectively, at the final visit. CIs were estimated by
fitting to binomial 95% CIs for these fractions. We modeled both LPT
species using a single force of infection, LL; this corresponds to a com-
mon transmission route, an assumption supported by the strongly
correlated distributions of T. mutans and T. velifera (see Results) and
consistent with their sharing the same tick vector, Amblyomma spp.
(The effects reported here are evenmore pronounced if the LPT species
are independently transmitted and modeled using separate force of in-
fections.) The parameters m and h were fitted as point estimates given
the observed numbers of acute ECF deaths and of clinical cases/deaths
relative to the model-derived estimate of the total number of calves
experiencing high-risk infections up to 51 weeks of age, V1. The model
fitting approach assumes that parameters are constant with age, which
is consistent with the serological data (see Fig. 2A) for LH and LL, the
RLBdata forLL andsL (Fig. 3C), and the age distribution of deaths for m
(Table 1), but cannot be tested directly for sH and h.
Model validation. We conducted a series of internal validation
tests of the model as follows: (i) predicting LPT prevalence by age in
surviving calves in the case-control study; (ii) predicting the age dis-
tribution of ECF deaths; and (iii) using observed prevalence at T-1 as theWoolhouse et al. Sci. Adv. 2015;1:e1400196 20 March 2015starting conditions, predicting the prevalence atT0by evaluating themodel
over a period of 5 weeks.
Scenarios and sensitivity analysis. Model-predicted, overall frac-
tions of exposed and high-risk calves during the first year of life (C1
and U1, respectively) and overall case fatality rate (CF1) were compared
for three scenarios: (A) varying LL alone, (B) varying LH alone, and (C)
varying both LH and LL by the same factor. As a sensitivity analysis, we
compared age-related changes in CF as predicted by the mathematical
model for four different parameter combinations: (1) baseline parameter
values as in Table 3; (2) doubling the force of infection for LPT (LL); (3)
setting the rate of recovery fromLPT infection (sL) to zero; and (4) both (2)
and (3).Wealso considered the effects of changing theprevalenceofLPTat
different ages, L(a). This was done first to generate an expected effect size
for thenatural challenge experiment (see above), and second to estimate the
expected impact of inoculation with LPT as a control measure. At a given
age a,C(a) was set to zero andL(a)was set to its value using baseline values
of theparametersLL andsLor0or1.The expectednumberofdeathsup to
52 weeks was calculated for each scenario, and effect sizes were calculated
using odds ratios.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/content/
full/1/2/e1400026/DC1
Fig. S1. Relationship of subclinical, clinical, and fatal infections to clinical variables.
Fig. S2. Relationship between clinical outcome and LPT prevalence.
Table S1. Conditional logistic regression analyses of clinical predictors.
Table S2. Impact of setting LPT prevalence at age a, L(a), on subsequent acute ECF death rate.
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